chrysophanic acid has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, R; Jiang, W; Li, L; Liu, X; Song, D; Xu, R; Zhang, C; Zhang, X | 1 |
| Kang, N; Liu, X; Wang, H; Wang, X; Xue, J; Yu, J; Zhang, N; Zhang, X | 1 |
2 other study(ies) available for chrysophanic acid and Apoplexy
| Article | Year |
|---|---|
Chrysophanol facilitates long-term neurological recovery through limiting microglia-mediated neuroinflammation after ischemic stroke in mice.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cytokines; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-6; Ischemic Stroke; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; Stroke | 2022 |
Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice.
Topics: Animals; Anthraquinones; Blood-Brain Barrier; Brain; Brain Ischemia; Carrier Proteins; Cerebral Infarction; Disease Models, Animal; Inflammasomes; Inflammation; Male; Mice; Microscopy, Confocal; NLR Family, Pyrin Domain-Containing 3 Protein; Permeability; Plant Extracts; Reperfusion Injury; Stroke | 2014 |